Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Neurocrine Biosciences describes compounds for increasing endogenous neuropeptide levels

Feb. 20, 1998

Warner-Lambert reveals new antipsychotic benzoxazinones

Feb. 20, 1998

Oxcarbazepine derivatives with potent anticonvulsant activity

Feb. 20, 1998

Betaseron slows progression of disability in secondary progressive MS

Feb. 19, 1998

Development of PNU-95666E moves ahead

Feb. 19, 1998

Hoechst prepares xanthines for cerebrovascular disorders

Feb. 19, 1998

Merck describes dopamine D4 receptor ligands with therapeutic potential

Feb. 18, 1998

tPA associated with neurotoxic effects in acute model of stroke

Feb. 17, 1998

IND approved for new formulation of lidocaine

Feb. 17, 1998

Elan announces completion of private placement for new company

Feb. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...